Electromed, Inc.
ELMD NYSE· Electromedical & Electrotherapeutic Apparatus
Last close · Oct 26, 2026
$26.62
KIRA · Stoqly’s AI analyst, in plain words
- Electromed, Inc. had $73.8M of revenue in fiscal 2026, up 15.3% on the year before. Over five years, revenue changed +15.6% a year on average.
- Its operating margin was 18.8%, up 3.7 pts: of every 100 in sales, about 19 is left after running the business.
- Electromed, Inc. made $11.3M of net profit in fiscal 2026. From fiscal 2017 to 2026, diluted EPS grew 19.6% a year.
- Free cash flow was $8.4M in fiscal 2026, 11.4% of revenue.
- Electromed, Inc. returned $3.9M to shareholders in fiscal 2026, 47% of free cash flow. The diluted share count fell 2.5%.
Market cap
$231M
P/E
20.5x
Revenue
$73.8M
Net income
$11.3M
Free cash flow
$8.4M
Operating margin
18.8%
Electromed, Inc. in 30 seconds · fiscal 2026
Are sales growing?
+15.3%
Yes. Sales grew 15.3% last year.
Does it make a profit?
15.3%
Yes. It keeps 15.3% of every sale as profit.
Does profit turn into cash?
11.4%
Yes. 11.4% of sales ends up as free cash.
How healthy are the accounts?
6 / 8
Mixed. It passes 6 of 8 health tests.
How is the share priced?
20.5x
One share costs 20.5 times its yearly profit per share.
What Electromed, Inc. does
No business description yet.
- Fiscal year ends
- June 30, 2026
- Latest annual report
- 10-K · Aug 25, 2026
- Legal name
- Electromed, Inc.
- CIK
- 0001488917
Electromed, Inc. · ELMD
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $41.7M | $48.1M | $54.7M | $64.0M | $73.8M |
| Revenue growth | 16.5% | 15.4% | 13.8% | 17.0% | 15.3% |
| Net interest income | $0.0M | $0.1M | $0.5M | — | — |
| Gross margin | 75.5% | 76.0% | 76.3% | 78.1% | 78.5% |
| Operating margin | 7.1% | 8.3% | 12.0% | 15.1% | 18.8% |
| Net income | $2.3M | $3.2M | $5.2M | $7.5M | $11.3M |
| Net margin | 5.5% | 6.6% | 9.4% | 11.8% | 15.3% |
| Diluted EPS | $0.26 | $0.36 | $0.58 | $0.85 | $1.30 |
| Cash | |||||
| Cash from operations | −$0.7M | $1.3M | $9.1M | $11.4M | $9.7M |
| Capital expenditure | $1.4M | $1.6M | $0.3M | $0.3M | $1.3M |
| Free cash flow | −$2.1M | −$0.3M | $8.8M | $11.1M | $8.4M |
| FCF margin | −5.1% | −0.7% | 16.0% | 17.4% | 11.4% |
| Share buybacks | $1.4M | $0.2M | $0.3M | $10.0M | $3.9M |
| Share count change | −1.6% | −0.8% | 1.9% | 0.6% | −2.5% |
| Debt and strength | |||||
| Cash and short-term investments | $8.2M | $7.4M | $16.1M | $15.3M | $20.5M |
| Shareholders' equity | $34.2M | $37.7M | $44.5M | $43.2M | $54.0M |
| Current ratio | 4.8x | 4.7x | 5.8x | 4.3x | 4.7x |
| Returns and quality | |||||
| Return on equity | 6.9% | 8.8% | 12.5% | 17.2% | 23.3% |
| Return on tangible equity | 6.9% | 8.5% | 11.7% | 17.6% | 21.1% |
| Piotroski F-score | 3 | 6 | 6 | 6 | 6 |
| Altman Z'' | 11.1 | 11.0 | 13.0 | 11.0 | 11.9 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$2.2M
3 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Electromed, Inc. · ELMD
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $26.62 a share, the company is worth $231M: 20.5 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0001488917). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.